A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Follicular Lymphoma

Type of Cancer
Lymphoma

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor, in Relapsed or Refractory Follicular Lymphoma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.